MED-EL USA has secured approval from the US Food and Drug Administration (FDA) for its Rondo 2 cochlear implant (CI) audio processor with wireless charging.
Claimed to be the first of its kind in the industry, the users can place the processor on the charge pad, which will charge automatically without wires or cables.
The rechargeable battery offers up to 18 hours of battery life, and will be fully recharged in four hours.
Rondo 2 features a sleek design with one on/off button and automatic volume control, in addition to its advanced wireless charging option.
The device also easily connects to cell phones and televisions with the support of intelligent wireless accessories.
In addition, Rondo 2 CI audio processor connects seamlessly with Bluetooth neckloops and hearing induction loops even in a busy room.
MED-EL North America CEO and president Raymond Gamble said: “RONDO 2 is the easiest to use CI audio processor ever made.
“And because MED-EL engineers every internal cochlear implant to be future-ready, all of our recipients will be able to enjoy the latest industry-leading audio processing technology.”
According to the company, recipients can customize their Rondo 2 to combine in with five neutral colors and hair patterned design covers.
For full submersion of Rondo 2, WaterWear reusable waterproof covers a can be used in any type of water such as salty seawater and chlorinated swimming pools.
The company is planning to make the product available to the customers in the fall of this year.
MED-EL Medical Electronics, which is an Austrian-based and privately owned business, supplies implantable hearing solutions to the customers.
With more than 1,900 employees, the group operates 30 subsidiaries across the globe.
MED-EL supplies a range of implantable and non-implantable solutions for the treatment of all types of hearing loss. Its products include cochlear and middle ear implant systems, combined electric acoustic stimulation hearing implant system and bone conduction devices.